WESPAC Advisors SoCal’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-412
Closed -$19K 115
2019
Q1
$19K Sell
412
-700
-63% -$35.1K 0.01% 177
2018
Q4
$49K Hold
1,112
0.03% 122
2018
Q3
$60K Buy
+1,112
New +$56.9K 0.03% 121
2018
Q2
Sell
-1,112
Closed -$69K 114
2018
Q1
$69K Hold
1,112
0.04% 104
2017
Q4
$68K Hold
1,112
0.04% 110
2017
Q3
$74K Hold
1,112
0.04% 115
2017
Q2
$86K Hold
1,112
0.06% 105
2017
Q1
$90.7K Hold
1,112
0.06% 105
2016
Q4
$80K Sell
1,112
-3,650
-77% -$264K 0.05% 105
2016
Q3
$370K Sell
4,762
-1,150
-19% -$92.9K 0.25% 62
2016
Q2
$461K Buy
5,912
+200
+4% +$15.9K 0.3% 50
2016
Q1
$468K Buy
5,712
+225
+4% +$18.3K 0.34% 48
2015
Q4
$489K Buy
+5,487
New +$466K 0.32% 51

Other funds holding CAH

WESPAC Advisors SoCal's CAH Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of Cardinal Health (CAH) in Q2 2019, closing a stake of 412 shares — an estimated $19K sold.

WESPAC Advisors SoCal first reported a position in CAH in Q4 2015 and held it in 13 quarters. The position peaked at $489K in Q4 2015. 686 funds tracked by Wall St. Rank hold CAH as of Q2 2019.

  • WESPAC Advisors SoCal reported no remaining Cardinal Health position as of Q2 2019 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 412 Cardinal Health shares in Q2 2019, an estimated $19K.
  • WESPAC Advisors SoCal first reported a position in Cardinal Health in Q4 2015 and held it in 13 quarters.
  • WESPAC Advisors SoCal's Cardinal Health position peaked at $489K in Q4 2015.
  • 686 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.